Durham NC 淋巴瘤临床试验
17项针对 淋巴瘤的研究正在 Durham及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
招募中2 期
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 距离 10 英里
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
招募中2 期
- Duke University, Durham
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
招募中1/2 期
- Duke University Medical Center, Durham
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
招募中1/2 期
- UNC School of Medicine, Division of Hematology, Chapel Hill · 距离 10 英里
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
招募中
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 距离 10 英里
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
招募中1/2 期
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 距离 10 英里
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
招募中3 期
- Duke Cancer Institute, Durham
DALY II USA/ MB-CART2019.1 for DLBCL
招募中2 期
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
招募中
- North Carolina Basnight Cancer Hospital, Chapel Hill · 距离 10 英里
Registry of Older Patients With Cancer
招募中观察性研究
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 距离 10 英里
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
招募中1/2 期
- Duke University Medical Center, Duke Cancer Center, Durham
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
招募中2 期
- University of North Carolina, Chapel Hill · 距离 10 英里
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
招募中
- Duke Cancer Institute, Durham
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
招募中1 期
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 距离 10 英里
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
招募中观察性研究
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 距离 10 英里
A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
招募中2 期
- Durham VA Medical Center, Durham, NC, Durham
其他城市的 淋巴瘤试验
- Houston, TX34 项研究
- New York City, NY33 项研究
- Boston, MA33 项研究
- Washington, DC23 项研究
- Baldwin Park, CA21 项研究
- Chicago, IL20 项研究
- St. Louis, MO15 项研究
- Philadelphia, PA15 项研究
- Cleveland, OH13 项研究
- Edison, NJ12 项研究
- Seattle, WA12 项研究
- Atlanta, GA11 项研究
Durham的其他研究
- 乳腺癌63 项研究
- 癌症（所有类型）59 项研究
- 非小细胞肺癌39 项研究
- 多发性骨髓瘤37 项研究
- 转移性癌症33 项研究
- 急性髓系白血病33 项研究
- 肺癌32 项研究
- 前列腺癌32 项研究
- 结直肠癌28 项研究
- 卵巢癌27 项研究
- 慢性淋巴细胞白血病27 项研究
- 心力衰竭26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。